Taken together, these data demonstrate pro-angiogenic, anti-fibrotic and cardioprotective roles for Flna and Nogo-B post-MI and provide mechanistic explanations for the improved vascularization and cardiac function induced by S100A8/A9 blockade. The gene discussed is FLNA; the disease is myocardial infarction.